Shanghai Lanyi Therapeutics Co., Ltd.

This early-stage trial is testing the safety of a new antibody drug called EA5 in adults with PNH, a rare blood disorder. The study will enroll about 24 patients to receive different doses of the drug over several weeks. Researchers will monitor for side effects and measure how t…